| Kanya Rajangam |
SNTI |
Common Stock |
Tax liability |
-12.6% |
|
|
-10,757 |
74,843 |
09 Mar 2026 |
Direct |
| Timothy K. Lu |
SNTI |
Common Stock |
Tax liability |
-11.2% |
|
|
-80,666 |
639,583 |
09 Mar 2026 |
Direct |
| Timothy K. Lu |
SNTI |
Common Stock |
Tax liability |
-0.58% |
|
|
-4,191 |
720,249 |
02 Feb 2026 |
Direct |
| Kanya Rajangam |
SNTI |
Common Stock |
Tax liability |
-1.59% |
|
|
-1,384 |
85,600 |
02 Feb 2026 |
Direct |
| Bryan Daniel Baum |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
43,900 |
43,900 |
18 Jul 2025 |
Direct |
| James J. Collins |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
21,950 |
21,950 |
25 Jun 2025 |
Direct |
| Feng Hsiung |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
21,950 |
21,950 |
25 Jun 2025 |
Direct |
| Fran Schulz |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
21,950 |
21,950 |
25 Jun 2025 |
Direct |
| BRENDA COOPERSTONE |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
21,950 |
21,950 |
25 Jun 2025 |
Direct |
| Donald F. Tang |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
21,950 |
21,950 |
25 Jun 2025 |
Direct |
| Mathers Edward T. |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
21,950 |
21,950 |
25 Jun 2025 |
Direct |
| Celadon Partners SPV 24 |
SNTI |
Common Stock |
Conversion of derivative security |
|
|
|
9,777,000 |
9,777,000 |
10 Mar 2025 |
Direct |
| Celadon Partners SPV 24 |
SNTI |
Series A Convertible Preferred Stock |
Conversion of derivative security |
-100% |
|
|
-9,777 |
0 |
10 Mar 2025 |
Direct |
| New Enterprise Associates 15, L.P. |
SNTI |
Common Stock |
Conversion of derivative security |
753% |
|
|
3,333,000 |
3,775,615 |
10 Mar 2025 |
Direct |
| New Enterprise Associates 15, L.P. |
SNTI |
Series A Convertible Preferred Stock |
Conversion of derivative security |
-100% |
|
|
-3,333 |
0 |
10 Mar 2025 |
Direct |
| Bayer Healthcare Llc |
SNTI |
Common Stock |
Conversion of derivative security |
378% |
|
|
2,222,000 |
2,809,848 |
10 Mar 2025 |
Direct |
| Bayer Healthcare Llc |
SNTI |
Series A Convertible Preferred Stock |
Conversion of derivative security |
-100% |
|
|
-2,222 |
0 |
10 Mar 2025 |
Direct |
| Kanya Rajangam |
SNTI |
Common Stock |
Conversion of derivative security |
|
|
|
33,000 |
33,000 |
10 Mar 2025 |
Iyer Family Revocable Trust dated Aug 26 2012 |
| Kanya Rajangam |
SNTI |
Series A Convertible Preferred Stock |
Conversion of derivative security |
-100% |
|
|
-33 |
0 |
10 Mar 2025 |
Iyer Family Revocable Trust dated Aug 26 2012 |
| Timothy K. Lu |
SNTI |
Common Stock |
Award |
782.6% |
|
|
642,358 |
724,440 |
07 Mar 2025 |
Direct |
| Kanya Rajangam |
SNTI |
Common Stock |
Award |
909% |
|
|
78,363 |
86,984 |
07 Mar 2025 |
Direct |
| Fran Schulz |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
43,900 |
43,900 |
07 Mar 2025 |
Direct |
| BRENDA COOPERSTONE |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
43,900 |
43,900 |
07 Mar 2025 |
Direct |
| Feng Hsiung |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
43,900 |
43,900 |
07 Mar 2025 |
Direct |
| Donald F. Tang |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
43,900 |
43,900 |
07 Mar 2025 |
Direct |
| John Harry Cross III |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
174,200 |
174,200 |
07 Mar 2025 |
Direct |
| James J. Collins |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
43,900 |
43,900 |
07 Mar 2025 |
Direct |
| Mathers Edward T. |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
43,900 |
43,900 |
07 Mar 2025 |
Direct |
| Timothy K. Lu |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
1,927,073 |
1,927,073 |
06 Mar 2025 |
Direct |
| Kanya Rajangam |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
235,088 |
235,088 |
06 Mar 2025 |
Direct |
| Timothy K. Lu |
SNTI |
Common Stock |
Sale |
-0.66% |
$2,376 |
$4.36 |
-545 |
82,082 |
06 Feb 2025 |
Direct |
| Kanya Rajangam |
SNTI |
Common Stock |
Sale |
-2.07% |
$795 |
$4.37 |
-182 |
8,621 |
06 Feb 2025 |
Direct |
| Timothy K. Lu |
SNTI |
Common Stock |
Sale |
-4.53% |
$15,963 |
$4.07 |
-3,922 |
82,627 |
04 Feb 2025 |
Direct |
| Kanya Rajangam |
SNTI |
Common Stock |
Sale |
-12.8% |
$5,279 |
$4.07 |
-1,297 |
8,803 |
04 Feb 2025 |
Direct |
| Bayer Healthcare Llc |
SNTI |
Warrant |
Purchase |
|
|
|
3,333,000 |
3,330,000 |
09 Dec 2024 |
Direct |
| Bayer Healthcare Llc |
SNTI |
Series A Convertible Preferred Stock |
Purchase |
|
|
|
2,222 |
2,222 |
09 Dec 2024 |
Direct |
| Donald F. Tang |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
12,500 |
12,500 |
09 Dec 2024 |
Direct |
| Fran Schulz |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
12,500 |
12,500 |
09 Dec 2024 |
Direct |
| Kanya Rajangam |
SNTI |
Common Stock Warrant (right to buy) |
Award |
|
|
|
49,500 |
49,500 |
09 Dec 2024 |
Iyer Family Revocable Trust dated Aug 26 2012 |
| Kanya Rajangam |
SNTI |
Series A Convertible Preferred Stock |
Award |
|
|
|
33 |
33 |
09 Dec 2024 |
Iyer Family Revocable Trust dated Aug 26 2012 |
| Mathers Edward T. |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
62,500 |
62,500 |
10 Jul 2024 |
Direct |
| Omid Farokhzad |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
62,500 |
62,500 |
10 Jul 2024 |
Direct |
| James J. Collins |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
62,500 |
62,500 |
10 Jul 2024 |
Direct |
| BRENDA COOPERSTONE |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
62,500 |
62,500 |
10 Jul 2024 |
Direct |
| Kanya Rajangam |
SNTI |
Common Stock |
Award |
|
|
|
101,000 |
101,000 |
01 Feb 2024 |
Direct |
| Kanya Rajangam |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
152,000 |
152,000 |
01 Feb 2024 |
Direct |
| Timothy K. Lu |
SNTI |
Common Stock |
Award |
54.7% |
|
|
306,000 |
865,496 |
01 Feb 2024 |
Direct |
| Timothy K. Lu |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
459,000 |
459,000 |
01 Feb 2024 |
Direct |
| DEBORAH KNOBELMAN |
SNTI |
Common Stock |
Award |
336.7% |
|
|
101,000 |
131,000 |
01 Feb 2024 |
Direct |
| DEBORAH KNOBELMAN |
SNTI |
Stock Option (Right to Buy) |
Award |
|
|
|
152,000 |
152,000 |
01 Feb 2024 |
Direct |